Morgan Stanley analyst Ryan Kenny downgrades SEI Investments (NASDAQ:SEIC) from Equal-Weight to Underweight.
Why Is HIV Drug Giant Gilead Stock Falling Monday?
Gilead's Phase 3 EVOKE-01 study on Trodelvy in metastatic non-small cell lung cancer didn't meet overall survival endpoint. Despite numerical OS improvement, further exploration is planned.